Tumor markers AFP Antibodies Product number 410-01, 411-01, 412-01 - α-fetoprotein (AFP) is produced during embryonic development and found in high concentrations in fetal serum. AFP has been shown to be elevated in patients with hepatocellular carcinoma. Detail CA125 Antibodies Product number 203-01R, 212-01R, 406-01, 407-01R, 408-01, 201-850, 205-485 - The CA125 monoclonal antibodies recognize epitopes in the protein core of the CA125 antigen. Detail CA15-3 Antibodies Product number 209-01R, 204-01R - The MUC-1 breast cancer antigen is a mucin-type glycoprotein. It is secreted from tumor cells and can be used as a serological marker of breast cancer. Detail CA19-9 - Antibodies Product number 103-01R, 106-01R - High affinity IgG1 monoclonal antibodies specific for sialylated Lewis-a (ie, the CA19-9 epitopes). Detail CanAg® AFP EIA Product number 600-10 - The CanAg AFP EIA kit is intended for the quantitative determination of α-Fetoprotein (AFP) in human serum. CE marked Detail CanAg® CA125 EIA Product number 400-10 - The CanAg CA125 EIA kit is intended for the quantitative determination of the cancer associated antigen CA125 in serum. CE marked Detail CanAg® CA15-3 EIA Product number 200-10 - The CanAg CA15-3 EIA kit is intended for the quantitative determination of the cancer associated antigen MUC-1 (CA15-3) in serum. CE marked Detail CanAg® CA19-9 EIA Product number 120-10 - The CanAg CA19-9 EIA kit is intended for the quantitative determination of the cancer associated antigen CA19-9 in serum. CE marked Detail CanAg® CA242™ EIA Product number 101-10 - The CanAg CA242 EIA kit is intended for the quantitative determination of CA242 cancer antigen in serum. CE marked Detail CanAg® CEA EIA Product number 401-10 - The CanAg CEA EIA kit is intended for the quantitative determination of the cancer associated antigen CEA in serum. CE marked Detail CanAg® CYFRA 21-1 EIA Product number 211-10 - The CYFRA 21-1 EIA kit is intended for the quantitative determination of soluble cytokeratin 19 fragments in human serum. The assay is to be used as an aid in monitoring disease progression during the course of disease and treatment in lung cancer patients. Serial testing for patient CYFRA 21-1 assay values should be used in conjunction with other clinical methods used for monitoring lung cancer. CE marked Detail CanAg® Free PSA EIA Product number 350-10 - The CanAg Free PSA EIA kit is intended for the quantitative determination of Free PSA (Prostate Specific Antigen) in human serum. CE marked Detail CanAg® ProGRP EIA Product number 220-10 - The CanAg ProGRP EIA kit is an immunoassay for the quantitative determination of ProGRP in serum. The CanAg ProGRP assay is to be used as an aid in the differential diagnosis and in monitoring disease progression during the course of disease and treatment in small cell lung cancer patients. Testing for patient proGRP assay values should be used in conjunction with other clinical methods used in the management of patients with small cell lung cancer. CE marked Detail CanAg® PSA EIA Product number 340-10 - The CanAg PSA EIA kit is intended for the quantitative determination of Total PSA (Prostate Specific Antigen) in human serum. CE marked Detail CanAg® SCC EIA Product number 800-10 - The CanAg SCC EIA kit is intended for the quantitative determination of squamous cell carcinoma (SCC) antigen in serum as an aid in the management of patients with squamous cell carcinoma. CE marked Detail CEA Antibodies Product number 401-01R, 402-01R - Epitope characterization has revealed five major antigenic domains of CEA, “Gold epitope 1-5”. Detail Free PSA Antibodies Product number 301-01, 326-01, 333-01 - The combination of antibodies against hidden epitopes of PSA with antibodies against exposed epitopes may be used for the development of specific assays for detection of Free PSA. Detail Fuc-GM1 Antibody Product number 105-01 - Fuc-GM1 is a sialic acid and fucose-containing glycolipid, which is expressed in small cell lung cancer and rarely detected in other types of cancer or normal tissues. Detail HE4 EIA Product number 404-10 - The HE4 EIA is an enzyme immunometric assay for the quantitative determination of HE4 in human serum. The assay is to be used as an aid in monitoring response to therapy for patients with invasive epithelial ovarian cancer. Serial testing for patient HE4 assay values should be used in conjunction with other clinical methods used for monitoring ovarian cancer. It is further intended to be used in conjunction with either ARCHITECT CA 125 II or CanAg CA125 EIA or Lumipulse G CA125II as an aid in estimating the risk of epithelial ovarian cancer in premenopausal and postmenopausal women presenting with pelvic mass. The results must be interpreted in conjunction with other methods in accordance with standard clinical management guidelines. CE marked Detail INNOTEST® hPLAP Product number 80326 - Enzyme immunoassay based on a unique monoclonal antibody for the quantitative determination of human placental alkaline phosphatase (hPLAP) in serum and heparinized plasma. CE marked Detail Lumipulse® G AFP-N (Alpha-Fetoprotein) Product number 292846 - Immunoreaction cartridges for in vitro diagnostic use with the LUMIPULSE G System for the quantitative measurement of alpha-fetoprotein (AFP) in serum or plasma. The assay utilises proven CLEIA (ChemiLuminescent Enzyme Immunoassay) technology with results that are available in up to 35 minutes. CE marked Detail Lumipulse® G CA125-II Product number 292631 - Immunoreaction cartridges for in vitro diagnostic use with the LUMIPULSE G System for the quantitative measurement of CA125 in serum or plasma. CE marked Detail Lumipulse® G CA15-3 Product number 292648 - For in vitro diagnostic use with the LUMIPULSE G System for the quantitative measurement of CA15-3 in serum or plasma. CE marked Detail Lumipulse® G CA19-9-N Product number 292655 - Immunoreaction cartridges for in vitro diagnostic use with the LUMIPULSE G System for the quantitative measurement of CA19-9-N in serum or plasma. CE marked Detail Lumipulse® G CEA-N (Carcinoembryonic Antigen) Product number 292662 - Immunoreaction cartridges for in vitro diagnostic (IVD) use with the LUMIPULSE G System for the quantitative measurement of carcinoembryonic antigen (CEA) in serum or plasma. CE marked Detail Lumipulse® G CYFRA (Cytokeratin Subunit 19 Fragment) Product number 292945 - Immunoreaction cartridges for in vitro diagnostic use with the LUMIPULSE G System for the quantitative measurement of cytokeratin subunit 19 fragment (CYFRA) in serum or plasma. CE marked Detail Lumipulse® G Free PSA (Free Prostate Specific Antigen) Product number 297766 - Immunoreaction cartridges for for in vitro diagnostic (IVD) use with the LUMIPULSE G System for the quantitative measurement of free prostate specific antigen (free PSA) in human serum or plasma. CE marked Detail Lumipulse® G HE4 (Human epididymis protein 4) Product number 234068 - Immunoreaction cartridges for in vitro diagnostics (IVD) use with the LUMIPULSE G System for the quantitative measurement of HE4 in human serum or plasma (sodium haparin, lithium heparin, or dipotassium EDTA) on the LUMIPULSE G System. CE marked Detail Lumipulse® G Mesothelin Product number 294192 - Immunoreaction cartridges for in vitro diagnostic (IVD) use with the LUMIPULSE G System for the quantitative determination Soluble Mesothelin Related Peptides (SMRP) in human serum or plasma. CE marked Detail Lumipulse® G Pepsinogen I Product number 292983 - Immunoreaction cartridges for in vitro diagnostic (IVD) use with the LUMIPULSE G System for the quantitative measurement of pepsinogen I in specimens based on CLEIA technology by two-step sandwich immunoassay method on the LUMIPULSE G system. CE marked Detail Lumipulse® G Pepsinogen II Product number 292990 - Immunoreaction cartridges for in vitro diagnostic (IVD) use with the LUMIPULSE G System for the quantitative measurement of pepsinogen Ⅱ in specimens based on CLEIA technology by two-step sandwich immunoassay on the LUMIPULSE G system. CE marked Detail Lumipulse® G PIVKA-II Product number 233184 - Immunoreaction cartridges for in vitro diagnostic (IVD) use with the LUMIPULSE G System for the quantitative measurement of protein induced vitamin K absence or antagonist-II (PIVKA-II) in serum. CE marked Detail Lumipulse® G ProGRP (Pro-Gastrin-Releasing Peptide) Product number 297858 - Immunoreaction cartridges for in vitro diagnostic (IVD) use with the LUMIPULSE G System for the quantitative measurement of Pro-gastrin-releasing peptide [ProGRP (31-98)] in serum or plasma. CE marked Detail Lumipulse® G PSA-N (Prostate Specific Antigen) Product number 292853 - Immunoreaction cartridges for in vitro diagnostic (IVD) use with the LUMIPULSE G System for the quantitative measurement of prostate specific antigen (PSA) in serum or plasma. CE marked Detail Lumipulse® G β2M-N (Beta 2-microglobulin) Product number 292914 - For in vitro diagnostics (IVD) use with the LUMIPULSE G System for the quantitative measurement of ß2-microglobulin (ß2m) in serum, plasma and urine. CE marked Detail Lumipulse® G β2M-N (Beta 2-microglobulin) Product number 292914 - Immunoreaction cartridges for in vitro diagnostic (IVD) use with the LUMIPULSE G System for the quantitative measurement of Beta 2-microglobulin (β2-m) in serum or plasma. CE marked Detail NSE Antibodies Product number 403-01R, 404-01R, 405-01R - The glycolytic enzyme enolase (2-phospho-D-glycerate hydrolase, EC 4.2.1.11) exists as several dimeric isoenzymes (αα,αβ, αγ, ββ and γγ). Detail Other Antibodies Product number 118-01R, 119-01R, 120-01, 121-01, 122-01, 124-01 - Upon request we may also supply the following antibodies targeting cancer-associated antigens. Detail S100/S100BB/S100A1B Antibodies Product number 740-01, 780-01 - The S100 proteins belong to the S100/calmodulin/troponin C super family of EF-hand calcium binding proteins. In brain tissue the dominating part of S100 consists of hetero- and homodimers of the α- and β-subunit (S100A1A1, S100A1B and S100BB). Detail Total PSA Antibodies Product number 304-01, 306-01, 310-01, 311-01 - Total PSA assays (ie, assays for determination of Free PSA and PSA-ACT) require the use of antibodies recognizing exposed epitopes (ie, epitopes that are not influenced by the complex formation between PSA and ACT). Detail
AFP Antibodies Product number 410-01, 411-01, 412-01 - α-fetoprotein (AFP) is produced during embryonic development and found in high concentrations in fetal serum. AFP has been shown to be elevated in patients with hepatocellular carcinoma. Detail
CA125 Antibodies Product number 203-01R, 212-01R, 406-01, 407-01R, 408-01, 201-850, 205-485 - The CA125 monoclonal antibodies recognize epitopes in the protein core of the CA125 antigen. Detail
CA15-3 Antibodies Product number 209-01R, 204-01R - The MUC-1 breast cancer antigen is a mucin-type glycoprotein. It is secreted from tumor cells and can be used as a serological marker of breast cancer. Detail
CA19-9 - Antibodies Product number 103-01R, 106-01R - High affinity IgG1 monoclonal antibodies specific for sialylated Lewis-a (ie, the CA19-9 epitopes). Detail
CanAg® AFP EIA Product number 600-10 - The CanAg AFP EIA kit is intended for the quantitative determination of α-Fetoprotein (AFP) in human serum. CE marked Detail
CanAg® CA125 EIA Product number 400-10 - The CanAg CA125 EIA kit is intended for the quantitative determination of the cancer associated antigen CA125 in serum. CE marked Detail
CanAg® CA15-3 EIA Product number 200-10 - The CanAg CA15-3 EIA kit is intended for the quantitative determination of the cancer associated antigen MUC-1 (CA15-3) in serum. CE marked Detail
CanAg® CA19-9 EIA Product number 120-10 - The CanAg CA19-9 EIA kit is intended for the quantitative determination of the cancer associated antigen CA19-9 in serum. CE marked Detail
CanAg® CA242™ EIA Product number 101-10 - The CanAg CA242 EIA kit is intended for the quantitative determination of CA242 cancer antigen in serum. CE marked Detail
CanAg® CEA EIA Product number 401-10 - The CanAg CEA EIA kit is intended for the quantitative determination of the cancer associated antigen CEA in serum. CE marked Detail
CanAg® CYFRA 21-1 EIA Product number 211-10 - The CYFRA 21-1 EIA kit is intended for the quantitative determination of soluble cytokeratin 19 fragments in human serum. The assay is to be used as an aid in monitoring disease progression during the course of disease and treatment in lung cancer patients. Serial testing for patient CYFRA 21-1 assay values should be used in conjunction with other clinical methods used for monitoring lung cancer. CE marked Detail
CanAg® Free PSA EIA Product number 350-10 - The CanAg Free PSA EIA kit is intended for the quantitative determination of Free PSA (Prostate Specific Antigen) in human serum. CE marked Detail
CanAg® ProGRP EIA Product number 220-10 - The CanAg ProGRP EIA kit is an immunoassay for the quantitative determination of ProGRP in serum. The CanAg ProGRP assay is to be used as an aid in the differential diagnosis and in monitoring disease progression during the course of disease and treatment in small cell lung cancer patients. Testing for patient proGRP assay values should be used in conjunction with other clinical methods used in the management of patients with small cell lung cancer. CE marked Detail
CanAg® PSA EIA Product number 340-10 - The CanAg PSA EIA kit is intended for the quantitative determination of Total PSA (Prostate Specific Antigen) in human serum. CE marked Detail
CanAg® SCC EIA Product number 800-10 - The CanAg SCC EIA kit is intended for the quantitative determination of squamous cell carcinoma (SCC) antigen in serum as an aid in the management of patients with squamous cell carcinoma. CE marked Detail
CEA Antibodies Product number 401-01R, 402-01R - Epitope characterization has revealed five major antigenic domains of CEA, “Gold epitope 1-5”. Detail
Free PSA Antibodies Product number 301-01, 326-01, 333-01 - The combination of antibodies against hidden epitopes of PSA with antibodies against exposed epitopes may be used for the development of specific assays for detection of Free PSA. Detail
Fuc-GM1 Antibody Product number 105-01 - Fuc-GM1 is a sialic acid and fucose-containing glycolipid, which is expressed in small cell lung cancer and rarely detected in other types of cancer or normal tissues. Detail
HE4 EIA Product number 404-10 - The HE4 EIA is an enzyme immunometric assay for the quantitative determination of HE4 in human serum. The assay is to be used as an aid in monitoring response to therapy for patients with invasive epithelial ovarian cancer. Serial testing for patient HE4 assay values should be used in conjunction with other clinical methods used for monitoring ovarian cancer. It is further intended to be used in conjunction with either ARCHITECT CA 125 II or CanAg CA125 EIA or Lumipulse G CA125II as an aid in estimating the risk of epithelial ovarian cancer in premenopausal and postmenopausal women presenting with pelvic mass. The results must be interpreted in conjunction with other methods in accordance with standard clinical management guidelines. CE marked Detail
INNOTEST® hPLAP Product number 80326 - Enzyme immunoassay based on a unique monoclonal antibody for the quantitative determination of human placental alkaline phosphatase (hPLAP) in serum and heparinized plasma. CE marked Detail
Lumipulse® G AFP-N (Alpha-Fetoprotein) Product number 292846 - Immunoreaction cartridges for in vitro diagnostic use with the LUMIPULSE G System for the quantitative measurement of alpha-fetoprotein (AFP) in serum or plasma. The assay utilises proven CLEIA (ChemiLuminescent Enzyme Immunoassay) technology with results that are available in up to 35 minutes. CE marked Detail
Lumipulse® G CA125-II Product number 292631 - Immunoreaction cartridges for in vitro diagnostic use with the LUMIPULSE G System for the quantitative measurement of CA125 in serum or plasma. CE marked Detail
Lumipulse® G CA15-3 Product number 292648 - For in vitro diagnostic use with the LUMIPULSE G System for the quantitative measurement of CA15-3 in serum or plasma. CE marked Detail
Lumipulse® G CA19-9-N Product number 292655 - Immunoreaction cartridges for in vitro diagnostic use with the LUMIPULSE G System for the quantitative measurement of CA19-9-N in serum or plasma. CE marked Detail
Lumipulse® G CEA-N (Carcinoembryonic Antigen) Product number 292662 - Immunoreaction cartridges for in vitro diagnostic (IVD) use with the LUMIPULSE G System for the quantitative measurement of carcinoembryonic antigen (CEA) in serum or plasma. CE marked Detail
Lumipulse® G CYFRA (Cytokeratin Subunit 19 Fragment) Product number 292945 - Immunoreaction cartridges for in vitro diagnostic use with the LUMIPULSE G System for the quantitative measurement of cytokeratin subunit 19 fragment (CYFRA) in serum or plasma. CE marked Detail
Lumipulse® G Free PSA (Free Prostate Specific Antigen) Product number 297766 - Immunoreaction cartridges for for in vitro diagnostic (IVD) use with the LUMIPULSE G System for the quantitative measurement of free prostate specific antigen (free PSA) in human serum or plasma. CE marked Detail
Lumipulse® G HE4 (Human epididymis protein 4) Product number 234068 - Immunoreaction cartridges for in vitro diagnostics (IVD) use with the LUMIPULSE G System for the quantitative measurement of HE4 in human serum or plasma (sodium haparin, lithium heparin, or dipotassium EDTA) on the LUMIPULSE G System. CE marked Detail
Lumipulse® G Mesothelin Product number 294192 - Immunoreaction cartridges for in vitro diagnostic (IVD) use with the LUMIPULSE G System for the quantitative determination Soluble Mesothelin Related Peptides (SMRP) in human serum or plasma. CE marked Detail
Lumipulse® G Pepsinogen I Product number 292983 - Immunoreaction cartridges for in vitro diagnostic (IVD) use with the LUMIPULSE G System for the quantitative measurement of pepsinogen I in specimens based on CLEIA technology by two-step sandwich immunoassay method on the LUMIPULSE G system. CE marked Detail
Lumipulse® G Pepsinogen II Product number 292990 - Immunoreaction cartridges for in vitro diagnostic (IVD) use with the LUMIPULSE G System for the quantitative measurement of pepsinogen Ⅱ in specimens based on CLEIA technology by two-step sandwich immunoassay on the LUMIPULSE G system. CE marked Detail
Lumipulse® G PIVKA-II Product number 233184 - Immunoreaction cartridges for in vitro diagnostic (IVD) use with the LUMIPULSE G System for the quantitative measurement of protein induced vitamin K absence or antagonist-II (PIVKA-II) in serum. CE marked Detail
Lumipulse® G ProGRP (Pro-Gastrin-Releasing Peptide) Product number 297858 - Immunoreaction cartridges for in vitro diagnostic (IVD) use with the LUMIPULSE G System for the quantitative measurement of Pro-gastrin-releasing peptide [ProGRP (31-98)] in serum or plasma. CE marked Detail
Lumipulse® G PSA-N (Prostate Specific Antigen) Product number 292853 - Immunoreaction cartridges for in vitro diagnostic (IVD) use with the LUMIPULSE G System for the quantitative measurement of prostate specific antigen (PSA) in serum or plasma. CE marked Detail
Lumipulse® G β2M-N (Beta 2-microglobulin) Product number 292914 - For in vitro diagnostics (IVD) use with the LUMIPULSE G System for the quantitative measurement of ß2-microglobulin (ß2m) in serum, plasma and urine. CE marked Detail
Lumipulse® G β2M-N (Beta 2-microglobulin) Product number 292914 - Immunoreaction cartridges for in vitro diagnostic (IVD) use with the LUMIPULSE G System for the quantitative measurement of Beta 2-microglobulin (β2-m) in serum or plasma. CE marked Detail
NSE Antibodies Product number 403-01R, 404-01R, 405-01R - The glycolytic enzyme enolase (2-phospho-D-glycerate hydrolase, EC 4.2.1.11) exists as several dimeric isoenzymes (αα,αβ, αγ, ββ and γγ). Detail
Other Antibodies Product number 118-01R, 119-01R, 120-01, 121-01, 122-01, 124-01 - Upon request we may also supply the following antibodies targeting cancer-associated antigens. Detail
S100/S100BB/S100A1B Antibodies Product number 740-01, 780-01 - The S100 proteins belong to the S100/calmodulin/troponin C super family of EF-hand calcium binding proteins. In brain tissue the dominating part of S100 consists of hetero- and homodimers of the α- and β-subunit (S100A1A1, S100A1B and S100BB). Detail
Total PSA Antibodies Product number 304-01, 306-01, 310-01, 311-01 - Total PSA assays (ie, assays for determination of Free PSA and PSA-ACT) require the use of antibodies recognizing exposed epitopes (ie, epitopes that are not influenced by the complex formation between PSA and ACT). Detail
